Member Info for RorkesDrift

Trust me Ken. I have worked for some of the most strategic brains in the life sciences industry. I suspect you haven't. Orphidian is a regulatory guy with some technical knowledge. Those guys have their niche but most of the really good ones don't have the insecurities that affect him. I know he us part of the BMN posse so understand your sticking up for him but he, like yourself, frequently mislead others by pretending to speak with authority you don't have. First instance Orphidians time line has been shown to be nonsense but many here took it to heart and your own approach to pricing leaves me incredulous. Please don't justify stoking to others to have a go at others who nearly pop your balloon.

I've got about 100m of post and rail fence to do. Trust me that ain't getting two coats.

Sorry our posts crossed. I understand what you are saying but given the posts tend to be cut and paste from the website coupled with optimistic conjecture why not just post the links. If you really want to help new investors then a bit more balance would help. There are some brilliant posters here but I notice that the congregation don't vote for them.

Daft thing is I suspect everyone here is invested and want the best for the company and the SP will do what it will. We might see less volatility if information was complete other than just numbers picked out of thin air.

Ken - do you still have the BMN recommendation pinned to the top of your twitter feed. My own calculations are anyone else following that advice would have lost £600 for every £1000 they invested

Hi Sonia

I know you have other reasons for being here but to be honest you could have invested in lots of other companies for the last few years and bought here in March. You may have made a lot more money - unless you invested during a placement it would have made no difference to the company

https://www.stockopedia.com/blog/can-you-beat-the-market-reading-stock-market-bulletin-boards-144414/

For me, as an opinion of one Ken your posts are heavy on opinion rather than facts and tend to lack a balanced analysis. I know you have your own following and the latest tactic of vote my post has probably been arrived at in a Telegram chat room.

Happy for you.

I posted the leaflet cause they use some form of carrier fluid but same company doing covid

https://www.orasure.com/innovation/innovation-in-development.asp

The other one is also investigating saliva -thats stated in next sentence ;-)

based test, E25Bio’s test relies on a patient’s nasopharyngeal swab. “It is incredibly difficult to find nasal swabs for our clinical trials at the moment. Our team is also working to determine if alternate samples, like saliva, can be considere

http://www.oraquick.com/What-is-OraQuick/How-Oral-Testing-Works

http://energy.mit.edu/news/mit-tata-center-startup-e25bio-produces-15-minute-tests-for-covid-19/
https://www.icenidiagnostics.com/news/rapid-covid-19-detection-iceni-diagnostics-offers-new-approach/

https://www.ama-assn.org/practice-management/cpt/cpt-code-approved-sars-cov-2-antigen-testing

From Sona website

"When completed, Sona’s Covid-19 test is expected to produce results in 5-15 minutes and is anticipated to cost less than $50. It will not require any additional laboratory-based equipment and can be administered by a layperson at the point of care."

April 13th Sona press release

April 13, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test. The Company this past week has:

Progressed from feasibility and prototype testing to the optimization stage for its Covid-19 antigen rapid response test;
Commenced work with two, third-party laboratories to prepare validation protocols;
Signed a memorandum of understanding to manufacture its test with a second contract manufacturer in North America;
Accepted pre-orders for a further 1,250,000 of the Company’s antigen detecting, rapid-response test; and

Thx

Lot of people on here and this could be an inflection point in their lives. Yet the bloke sounds quite humble really - think St Peter will lay out red carpet for him and his one day - covid testing is what the world needs now and if they can improve chemo then double wow. Who knew Yorkshire could offer so much.

Ionic = in clinic. Bliddy spool chucker

If they can bank £300M a month (mix of price or volume your choice but note CoGs is £2 and tender price is £10) then after a year just in cash its a 10 bagger. Duringbthat year the cancer drugs will be in ionic.

More uncertain is affimer neutralising but I'd be nervous if I was the competition

They were expecting other diagnostics to finalise (d-dimer and E2) end 2019.

I can understand why at least 4 posts a day say RNS tomorrow.

Thanks for posting - 100m test per month at say £3 contribution = £300M per month.

MKT cap is....

Wara teg

Hope this helps.

https://www.gov.uk/guidance/working-safely-during-coronavirus-covid-19

Just had a quick look at Abingdon Healths accounts (that is a scary set of books).

CoGs were 30% of revenue. Company made a significant loss overall.

There are economies of scale in manufacturing of course but I believe AS was aware of this when he states £2 for CoGs. Furthermore, there is a significant supply chain all of whom will require margin. It is possible to create some verticle integration (Awacta buy Abingdon Health / set up own manufacturing) .

Most people who have had a stab at the numbers here have used a fairly low contribution (£1-£5). They also have a horizon that is shorter than the emergence of significant competition. Avacta exceeds £1B in most old them (my own is £3B).

AS has stated a price of as high as £30 but £10 for tender. The later is not one factory - it is organisations such the NHS, Tesco, Amazon. I am struggling to find a scenario where the price drops to £2 especially if that is driven by the inabilities of a business to pay more. Economics doesn't work like that.

The good news is that the government are likely to buy the mass majority of tests and work with businesses - indeed the later will be crucial to deliver testing. I would also expect some guidance from HSE to the level of testing required for different industries - I can imagine meat packing requires every day (and supplied by PHE).

We are already considering bonusing staff for our overall attendance rate - not individuals - if you are showing any symptoms stay home and kept your colleagues stay disease free. That said they are an intelligent, well motivated work force.

I think I might have had too much Pendyrn myself. RK your comment about volumes reminds me of a sales manager I had to "have a word with". We had a couple of product lines under licence which supported our overall offer but it meant CoGs were about 55%. He decided to do a buy one, get one free deal. Sold shed loads of volume.

Not joking.